Understanding the source to patient journey

How does a plant become a medicine? It’s a complicated process, and is one of the reasons why natural medicines can vary considerably depending on how they are produced.

Flordis adheres to a strict ‘quality first’ approach to ingredient sourcing and manufacturing in order to help ensure that our products are best-in-class and supported by product specific clinical evidence.

That’s why careful attention is applied to plant species and growing methods through to cultivation and harvest, by using precise processes to help produce consistent crops. The extraction and manufacturing of specific ingredients then follows a series of strict controls to help deliver a consistent medicine from one batch to the next.

It is this specific medicine that is tested in clinical trials, and it’s this same medicine that you as a consumer will receive. This consistency means that you can be more confident you may enjoy the same health benefits that were identified during the clinical research.

At Flordis, this rigorous end-to-end process is what we like to call the ‘seed to patient journey’ –where the following steps involved in the growth and manufacture of the natural medicine are tightly controlled to reduce variability and to help ensure consistency.

At Flordis, this rigorous end-to-end process is what we like to call the ‘source to patient journey’, where all of the steps involved in the growth and manufacture of the natural medicine are tightly controlled to reduce variability and to help ensure consistency.

The Flordis source to patient journey:

Consistent raw materials

Wherever possible our cultivation methods observe Good Agricultural Practices (GAP) by working closely with farmers and other partners. Other elements involved in the source-to-patient process include the careful selection of the exact species and standardisation of propagation, cultivation and harvesting. These controls play a large part in contributing to raw materials with a consistent phytochemical profile.

Consistent extraction and manufacture of finished product

The source-to-patient process also demands more than the observation of Good Manufacturing Practice (GMP). The standardisation of all inputs and processes is essential to help ensure product consistency from one batch to the next, often referred to as batch to batch consistency. A series of strict controls are applied to the manufacturing processes, including solvents used and the methods of extraction, through to the packaging, storage and transportation of the finished natural medicines.

Clinical research

The final stage in the source-to-patient process is to conduct research and clinical trials to substantiate safety and efficacy of finished products, with the results from clinical studies validated by publication in respected peer-reviewed scientific journals. Our batch to batch consistency means that the specific medicine tested in clinical trials is the same medicine used in Flordis products.

By applying this high standard, Flordis delivers a specialised portfolio of world class natural medicines that are well tolerated and effective, resulting in highly reliable health outcomes.

And this is one of the reasons why Flordis natural medicines are recommended to millions of people worldwide – and why you can feel confident you’re taking a quality natural medicine when you choose Flordis.

The Source to Patient Philosophy

The six step Source to Patient philosophy

Consistent raw materials

Step 1. Plant selection and propagation

Step 2. Cultivation and collection

Step 3. Harvesting and processing 

Consistent extraction and manufacture of finished product

Step 4. Extraction and manufacturing

Step 5. Packaging, storage and transportation

Research and clinical studies

Step 6 Research and clinical studies on exact product

More from Flordis

Prospan

Chesty cough relief for the whole family
Learn more

KeenMind

Supports memory, concentration and learning retention
Learn more

KeenMind pack